genedrive plc (GDR)-製薬・医療分野:企業M&A・提携分析

GlobalDataが発行した調査報告書(DATA8013190)
◆英語タイトル:genedrive plc (GDR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013190
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:39
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
genedrive plc (genedrive), formerly Epistem Holdings plc is a molecular diagnostics company. The company focuses on the development and commercialization of simple to use “point of need” system or point of care diagnostics platform for the diagnosis of infectious diseases and use in patient genotyping, pathogen detection and other indications. It also provides contract research services novel and transferable preclinical models and services to support decision making throughout the drug discovery and development pipeline to other pharmaceutical companies, as well as GCLP accredited gene expression and genotype analysis for drug development and diagnostic programs. genedrive is headquartered in Manchester, the UK.

genedrive plc (GDR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
genedrive plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
genedrive plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
genedrive plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
genedrive plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
genedrive plc, Medical Devices Deals, 2011 to YTD 2017 9
genedrive plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
genedrive plc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Epistem Enters Into Co-Development Agreement With ScandiDerma 11
Licensing Agreements 12
Epistem Holdings and CRT Enter into Licensing Agreement with Newcastle University 12
Equity Offering 13
Epistem Holdings to Raise USD9.37 Million in Private Placement of Shares 13
Epistem Announces Private Placement Of Shares For US$7 Million 14
Epistem Holdings Completes Private Placement Of Common Stock For US$4.3 Million 15
genedrive plc – Key Competitors 16
genedrive plc – Key Employees 17
genedrive plc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Oct 17, 2017: Genedrive Announces its audited Preliminary Results for the year ended 30 June 2017 19
Mar 30, 2017: Genedrive: Interim Results for the six month period to 31 December 2016 23
Oct 11, 2016: Genedrive Announces Preliminary Results for the year ended 30 June 2016 24
Mar 31, 2016: Epistem Holdings: Interim Results to 31 December 2015 29
Corporate Communications 32
Nov 08, 2017: genedrive: Directorate Change 32
Nov 29, 2016: genedrive: Update on CFO Appointment 33
Sep 21, 2016: Genedrive Announces Appointment of Chief Financial Officer 34
Jan 13, 2016: Epistem Appoints David Budd as Chief Executive Officer 35
Jan 13, 2016: Epistem Appoints David Budd at Chief Executive Officer 36
Other Significant Developments 37
Jul 25, 2016: Epistem Holdings Announces Re change of name, TIDM and website address 37
Jul 11, 2016: Epistem Holdings Announces Result of General Meeting and Change of Name 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
genedrive plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
genedrive plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
genedrive plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
genedrive plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
genedrive plc, Deals By Therapy Area, 2011 to YTD 2017 8
genedrive plc, Medical Devices Deals, 2011 to YTD 2017 9
genedrive plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Epistem Enters Into Co-Development Agreement With ScandiDerma 11
Epistem Holdings and CRT Enter into Licensing Agreement with Newcastle University 12
Epistem Holdings to Raise USD9.37 Million in Private Placement of Shares 13
Epistem Announces Private Placement Of Shares For US$7 Million 14
Epistem Holdings Completes Private Placement Of Common Stock For US$4.3 Million 15
genedrive plc, Key Competitors 16
genedrive plc, Key Employees 17
genedrive plc, Subsidiaries 18

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ genedrive plc (GDR)-製薬・医療分野:企業M&A・提携分析(genedrive plc (GDR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆